WT1 and ovarian carcinoma: Determination of WT1 expression by an immunohistochemical method on ovarian carcinoma specimens showed that around 50% of ovarian carcinoma samples possessed a high level of WT1 expression and the expression level had a negative impact on the survival rate of this cancer [21, 22].